{"nct_id":"NCT05267470","title":"A Study of Bemarituzumab Monotherapy and Combination With Other Anti-cancer Therapy in SqNSCLC With FGFR2b Overexpression (FORTITUDE-201)","status":"TERMINATED","status_verified_date":"2025-02","start_date":"2022-03-29","start_date_type":"ACTUAL","primary_completion_date":"2024-05-28","primary_completion_date_type":"ACTUAL","completion_date":"2024-05-28","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["AMGN"]}